Klimkait T - Search Results

1

A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.

Fagard C, Oxenius A, Günthard H, Garcia F, Le Braz M, Mestre G, Battegay M, Furrer H, Vernazza P, Bernasconi E, Telenti A, Weber R, Leduc D, Yerly S, Price D, Dawson SJ, Klimkait T, Perneger TV, McLean A, Clotet B, Gatell JM, Perrin L, Plana M, Phillips R, Hirschel B; Swiss HIV Cohort Study. Fagard C, et al. Among authors: klimkait t. Arch Intern Med. 2003 May 26;163(10):1220-6. doi: 10.1001/archinte.163.10.1220. Arch Intern Med. 2003. PMID: 12767960 Free article.

2

Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. Swiss HIV Cohort Study.

Khanna N, Klimkait T, Schiffer V, Irigoyen J, Telenti A, Hirschel B, Battegay M. Khanna N, et al. Among authors: klimkait t. AIDS. 2000 May 5;14(7):791-9. doi: 10.1097/00002030-200005050-00004. AIDS. 2000. PMID: 10839586

3

Impact of protease polymorphisms and viral fitness on human immunodeficiency virus (HIV) type 1 viremia in untreated HIV-1 infection.

Märki Y, Kaufmann GR, Battegay M, Klimkait T; Swiss HIV Cohort Study. Märki Y, et al. Among authors: klimkait t. J Infect Dis. 2002 Jun 15;185(12):1844-6. doi: 10.1086/340842. J Infect Dis. 2002. PMID: 12085340 No abstract available.

4

Association of a pool of HIV-1 with erythrocytes in vivo: a cohort study.

Hess C, Klimkait T, Schlapbach L, Del Zenero V, Sadallah S, Horakova E, Balestra G, Werder V, Schaefer C, Battegay M, Schifferli JA. Hess C, et al. Among authors: klimkait t. Lancet. 2002 Jun 29;359(9325):2230-4. doi: 10.1016/S0140-6736(02)09291-7. Lancet. 2002. PMID: 12103286

5

[Adherence and resistance].

Klimkait T, Vernazza P. Klimkait T, et al. Ther Umsch. 2004 Oct;61(10):631-4. doi: 10.1024/0040-5930.61.10.631. Ther Umsch. 2004. PMID: 15532193 German.

6

Opinion paper. Resistance to new anti-HIV agents: problems in the pathway of drug registration.

Dalmau D, Klimkait T, Telenti A. Dalmau D, et al. Among authors: klimkait t. Antivir Ther. 2005;10(7):867-72. Antivir Ther. 2005. PMID: 16312184

7

Genotypic and phenotypic resistance testing of HIV-1 in routine clinical care.

Hirsch HH, Drechsler H, Holbro A, Hamy F, Sendi P, Petrovic K, Klimkait T, Battegay M. Hirsch HH, et al. Among authors: klimkait t. Eur J Clin Microbiol Infect Dis. 2005 Nov;24(11):733-8. doi: 10.1007/s10096-005-0044-4. Eur J Clin Microbiol Infect Dis. 2005. PMID: 16328557

8

Stable virulence levels in the HIV epidemic of Switzerland over two decades.

Müller V, Ledergerber B, Perrin L, Klimkait T, Furrer H, Telenti A, Bernasconi E, Vernazza P, Günthard HF, Bonhoeffer S; Swiss HIV Cohort Study. Müller V, et al. Among authors: klimkait t. AIDS. 2006 Apr 4;20(6):889-94. doi: 10.1097/01.aids.0000218553.51908.6b. AIDS. 2006. PMID: 16549973

9

Cost-effectiveness of genotypic antiretroviral resistance testing in HIV-infected patients with treatment failure.

Sendi P, Günthard HF, Simcock M, Ledergerber B, Schüpbach J, Battegay M; Swiss HIV Cohort Study. Sendi P, et al. PLoS One. 2007 Jan 24;2(1):e173. doi: 10.1371/journal.pone.0000173. PLoS One. 2007. PMID: 17245449 Free PMC article.

10

The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial.

Vernazza P, Daneel S, Schiffer V, Decosterd L, Fierz W, Klimkait T, Hoffmann M, Hirschel B. Vernazza P, et al. Among authors: klimkait t. AIDS. 2007 Jun 19;21(10):1309-15. doi: 10.1097/QAD.0b013e32814e6b1c. AIDS. 2007. PMID: 17545707

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

469 results

Search Page

Filters